Navigation Links
BioVentures in Medical News

Apex Bioventures Acquisition Corp. Sets Date for Special Meeting of Stockholders to Approve Dissolution

HILLSBOROUGH, Calif., May 7 /PRNewswire-FirstCall/ -- Apex Bioventures Acquisition Corporation (NYSE Amex: PEX ) ("Apex") announced today that a special meeting of stockholders will be held at 10:00 a.m. local time on Tuesday, June 2, 2009, at the offices of Mintz Levin Cohn Ferris Glovsky &...

Apex Bioventures Acquisition Corp. To Seek Stockholder Approval To Liquidate and Dissolve

HILLSBOROUGH, Calif., March 5 /PRNewswire-FirstCall/ -- Apex Bioventures Acquisition Corporation (NYSE Alternext US: PEX) ("Apex") announced today that its board of directors has determined that Apex will not consummate a business combination in the time frame required by its Second Amended and Re...

Rcadia Medical Imaging Closes $3.3 Million Investment Led by BioVentures Investors

BOSTON, Dec. 15 /PRNewswire/ -- Rcadia Medical Imaging, Ltd., developer of the COR Analyzer(TM) software for the automated analysis of coronary CT angiography (CCTA) studies, has closed a $3.3M investment round led by BioVentures Investors of Cambridge, MA, Rcadia announced today. Existing investo...

Apex Bioventures Announces Trust Investment Details

HILLSBOROUGH, Calif., Oct. 14 /PRNewswire-FirstCall/ -- In light of recent events impacting the global financial markets, Apex Bioventures Acquisition Corp. (Amex: PEX ), a publicly traded special purpose acquisition company with healthcare industry expertise, announced today details related ...

Echo Therapeutics and Cato BioVentures Sign Right of First Offer Agreement for Dermatology Products and Transdermal Drug Delivery Technologies

FRANKLIN, Mass., April 21 /PRNewswire-FirstCall/ -- Echo Therapeutics (OTC Bulletin Board: ECTE) today announced that it has signed a dermatology product and transdermal drug delivery technology right of first offer agreement with Cato BioVentures, the venture capital affiliate of Cato Researc...

Catalyst Biosciences Announces Agreement With MedImmune to Discover and Develop Engineered Protease Therapeutics

... Essex Woodlands Health Ventures, HealthCare Ventures, Johnson & Johnson Development Corporation, Morgenthaler Ventures, Novartis BioVentures, RCT bioventures and Sofinnova Ventures. For more information, please visit www.catbio.com . Catalyst Biosciences, Inc. Erik Wiberg +1.650.266.865...

Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products

... Essex Woodlands Health Ventures, HealthCare Ventures, Johnson & Johnson Development Corporation, Morgenthaler Ventures, Novartis BioVentures, RCT bioventures and Sofinnova Ventures. For more information, please visit www.catbio.com . About Wyeth Pharmaceuticals Wyeth Pharmaceuticals, a division...

Ceregene Presents Additional Clinical Data from Phase 2 Trial of CERE-120 for Parkinson's Disease

...001. The company's investors include Alta Partners, MPM Capital, Investor Growth Capital and Cell Genesys, Inc. (Nasdaq: CEGE ) as well as Hamilton bioventures and California Technology Partners. Contacts: Jeffrey M. Ostrove, Ph.D. President and CEO Ceregene, Inc. ...

SCOLR Pharma, Inc. Reports First Quarter 2009 Financial Results

...tic that we will be able to reach agreement with suitable partner(s) to commercialize these products. We recently announced that we retained HealthPro bioventures LLC ("HealthPro"), a life science investment bank and strategic advisory firm, to assist us in our partnership activities. We continue to be very enc...

SCOLR Pharma, Inc. Announces Engagement of HealthPro as Financial Advisor

... BOTHELL, Wash., April 2 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (NYSE Alternext US: DDD) today announced the engagement of HealthPro bioventures LLC ("HealthPro"), a life sciences investment bank and strategic advisory firm, as its financial advisor in connection with the evaluation of various ...
BioVentures in Medical Technology

Cordex Pharma Announces Strategic Master Services Equity Agreement With Cato BioVentures

Phase 3 clinical oversight and regulatory services for Cordex's ATPace arrhythmia drug to be provided by Cato Research LA JOLLA, Calif., Feb. 23 /PRNewswire-FirstCall/ -- Cordex Pharma, Inc. (OTC Bulletin Board: CDXP) announced today that it has entered into a long-term strategic master servi...

S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis

...team. S*BIO has strong links with a network of medical oncologists in Asia Pacific and its investors include Bio*One Capital, Aravis Venture, Novartis bioventures and other international funds. More information about S*BIO can be found at www.sbio.com . S*BIO Pte Ltd: Stephen Keith Rhind, Ph...

S*BIO Initiates U.S. Phase I Clinical Trials of Oral JAK2 Inhibitor SB1518 for the Treatment of Hematological Malignancies

...cal development team. S*BIO has strong links with a network of medical oncologists in Asia Pacific and its investors include Bio*One Capital, Novartis bioventures and other international funds. More information about S*BIO can be found at http://www.sbio.com . S*BIO Pte Ltd: Stephen Keith Rhind, Ph.D. Sen...

Abeome and Cato Research to Collaborate on Ovarian Cancer Therapeutic

...ounced today a strategic equity investment by Cato bioventures and a collaboration with Cato Research Ltd., its g....abeomecorp.com . About Cato BioVentures Cato bioventures is the venture capital affiliate of Cato Research ...ic CRO service agreements with Cato Research, Cato bioventures invests its in-kind CRO Service Capital(TM) in inn...

Arriva Pharmaceuticals Moves Forward to Phase 2b Development of Lead Inhaled Protein rAAT Replacement Therapy for Hereditary Emphysema

... Nordic Biotech II K/S and MPM bioventures close on additional $6 million investment on top of $75 million previous investment AMSTERDAM, Netherlands and ALAMEDA, Calif., Feb. 28 /PR...

Ceregene Presents Long-term Follow-up From Phase 1 Trial of CERE-120 in Parkinson's Disease

...nesys, Inc. (Nasdaq: CEGE ). The company's investors include Alta Partners, MPM Capital, Investor Growth Capital and Cell Genesys as well as Hamilton bioventures and California Technology Partners. ...

Preclinical Data on Cytogen's Technology to be Reported at the AACR Annual Meeting

... and external research collaborations, Cytogen is exploring strategic transactions for AxCell BioSciences and will be presenting at the 9th Annual C21 bioventures Conference (C21) taking place in Monterey, California May 22-24, 2007. -0- Additional details for the AACR presentations are as follows: Pre...

Ceregene Presents Long Term Follow-Up Data From Phase 1 Trial of CERE-120 Demonstrating Improved Motor Function in Parkinson's Patients

...red in South San Francisco, CA. Ceregene's investors include Alta Partners, MPM Capital, Investor Growth Capital and Cell Genesys, as well as Hamilton bioventures and, California Technology Partners. About The Michael J. Fox Foundation Founded in 2000, The Michael J. Fox Foundation for Parkinson's Research i...

Ceregene Presents Interim Phase 1 Clinical Data of CERE-110 for the Treatment of Alzheimer's Disease

...red in South San Francisco, CA. Ceregene's investors include Alta Partners, MPM Capital, Investor Growth Capital and Cell Genesys, as well as Hamilton bioventures and, California Technology Partners. Contact: Jeffrey M. Ostrove, Ph.D. President and CEO Ceregene, Inc. (858) 458-880...

Cytogen Reports Publication Validating the Utility of its Proprietary ProChart Database

...xternal research collaborations, Cytogen is exploring strategic transactions for AxCell BioSciences and will be presenting today at the 9th Annual C21 bioventures Conference (C21) taking place in Monterey, California. About ProChart(TM) ProChart is a proprietary, comprehensive, experimentally validated datab...
BioVentures in Biological Technology

Apex Bioventures Acquisition Corporation Receives Notice of Extension from NYSE Amex

HILLSBOROUGH, Calif., May 11 /PRNewswire-FirstCall/ -- Apex Bioventures Acquisition Corporation (NYSE Amex: PEX ) (the "Company") announced today that it has received notice from NYSE Amex LLC (the "Exchange") that the plan of compliance submitted by the Company has been accepted by the Exchange...

Newbridge Securities Corporation Forms BioVentures Division

Newbridge Expands its Presence in the Biotech Industry FT. LAUDERDALE, Fla., Feb. 17 /PRNewswire/ -- Newbridge Securities Corporation ("Newbridge"), a full-service securities broker-dealer and investment bank, is proud to announce the formation of the Newbridge BioVentures Division ("NBV"). N...

Lorus Therapeutics Announces Exclusive Multinational License Agreement with Zoticon Bioventures for Virulizin(R)

- Agreement includes upfront, milestone and royalty payments on future sales - TORONTO, April 8 /PRNewswire-FirstCall/ - Lorus Therapeutics Inc. ("Lorus") (TSX: LOR; AMEX: LRP), a biopharmaceutical company dedicated to the research and development of pharmaceuti...

Ceregene Receives Additional Grant From Michael J. Fox Foundation to Expand Long-Term Testing of CERE-120 Patients

...001. The company's investors include Alta Partners, MPM Capital, Investor Growth Capital and Cell Genesys, Inc. (Nasdaq: CEGE ) as well as Hamilton bioventures and California Technology Partners. ...

Intellikine Completes $51 Million Financing

... the treatment of cancer, inflammation and autoimmune diseases, announced today that it has raised $51 million in preferred stock financing. Novartis bioventures Ltd. led the financing in which additional new investors U.S. Venture Partners, Biogen Idec and FinTech Global Capital participated. Markus Goebel, M...

NexGen Biofuels Ltd Signs Letter of Intent for the Purchase of World Venture Management, Inc. Assets and the Sale of its Current Business

...ral Gas, in the United States in consideration for a controlling stake in NexGen and (ii) the purchase of NexGen's holdings in its subsidiaries by Mac bioventures in consideration for a part of the debt it's assuming in NexGen. The Letter of Intent further contemplates that the number of shares up to 65 m...

Accera, Inc. to Present at Upcoming Investor Conferences

...O Venture Conference on April 1 at 10:15 a.m. EDT at the Sheraton Boston Hotel in Boston, MA. On April 9 at 11:30 a.m. PDT, he will present at the C21 bioventures Conference at the Meritage Resort in Napa Valley, CA. In early March, the company launched Axona(TM), a medical food available only by prescripti...

Catalyst Biosciences Expands Scientific Advisory Board With Leading Experts in Protease Therapeutic Discovery and Development

... Essex Woodlands Health Ventures, HealthCare Ventures, Johnson & Johnson Development Corporation, Morgenthaler Ventures, Novartis BioVentures, RCT bioventures and Sofinnova Ventures. For more information, please visit www.catbio.com . Catalyst Biosciences, Inc. Erik Wiberg Chief Financial...

S*BIO Receives BioSpectrum Editor's Choice, Emerging BioScience Company of Singapore Award

...dical oncologists in Asia Pacific and its investors include EDB Investments' biomedical sciences subsidiary Bio*One Capital, Aravis Ventures, Novartis bioventures and other international funds. More information about S*BIO can be found at www.sbio.com . S*BIO Pte Ltd: Russo Partner...

Sopherion Therapeutics Secures $55 Million in Series C Funding

...toxicity while preserving antitumor efficacy. In January 2008, Zoticon bioventures in-licensed Myocet and provided funding of $20 million to Sopherion and sub...merica. For more information, visit www.sopherion.com . About Zoticon bioventures Zoticon is a privately held global drug development and healthcare inv...
BioVentures in Biological Products

BioTracker Dye 1ml from BioVentures

Description: "BioTracker 6X Bromophenol Blue Tracking Dye is composed of 60% St DI H2O, 30% Glycerol, 10% 10XTE, 0.25% BPB Dye and 0.85% SDS....
Company:BioVentures
Other Tags
(Date:10/22/2014)... (PRWEB) October 22, 2014 Best Cheap ... in the world. The site has recently announced that ... hosting supplier for people from around the world. , ... in operation today and is providing various kinds of ... the company insists on offering excellent customer service and ...
(Date:10/22/2014)... 2014 Although there are only 24 hours in ... people who have trouble finding time within their busy schedules for ... long periods of time to get in shape. Here are five ... the go. , Change Up Your Commute , Consider riding ... add some exercise into your daily routine. If you must use ...
(Date:10/22/2014)... MA (PRWEB) October 22, 2014 ... new solutions for the treatment of bacterial infections, microbial ... Sinskey has joined its board of directors. , ... and Engineering Systems at The Massachusetts Institute of Technology, ... MIT faculty since 1968. Dr. Sinskey also holds positions ...
(Date:10/22/2014)... (HealthDay News) -- Two sisters in high school have ... Ilina and Medha Krishen use electronic stethoscopes, which electronically ... in breathing patterns or heartbeats. Ilina, a senior ... to find a way to detect early lung damage ... electronic stethoscope, Ilina recorded one breath cycle each from ...
(Date:10/22/2014)... Oct. 21, 2014 (HealthDay News) -- Measures taken by ... in Ebola-ravaged Liberia may have limited the spread of ... report. The Firestone Natural Rubber Co. provides health ... residents of nearby densely populated communities. Between Aug. ... suspected Ebola cases among those 80,000 people. That incidence ...
Breaking Medicine News(10 mins):Health News:Best Cheap Hosting USA Has Recently Announced The Best Cheap Web Hosting Companies In 2014 2Health News:HealthGuideMD Presents Ways to Improve Your Exercise and Fitness 2Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Teen Sisters Develop Ways to Measure Lung, Heart Damage 2Health News:Tire Company Sets Standard for Ebola Care in Liberia: CDC 2
(Date:10/15/2014)... , Oct. 15, 2014   Neurotechnology , ... announced the availability of the VeriLook Surveillance ... 3.0 provides real-time biometric face identification using live ... surveillance cameras. The new version not only identifies ... people from objects while they are moving through ...
(Date:10/14/2014)... of years since T. rex took its ... scientists is breathing life back into dinosaurs using high-powered ... research has important implications for how dinosaurs used their ... sense of smell and cool their brains. , ... student Jason Bourke, lead author of the new study ...
(Date:10/14/2014)... kind of stem cell that can become either a liver ... to a study published today in the journal Stem ... contradicts current theory on how organs arise from cell layers ... and future treatment for, liver cancer., Thanks to stem cells, ... made up of more than 200 cell types. The original, ...
Breaking Biology News(10 mins):VeriLook Surveillance 3.0 SDK Identifies Faces and Moving Objects, Differentiates Pedestrians from Other Moving Objects in Video Surveillance Systems 2VeriLook Surveillance 3.0 SDK Identifies Faces and Moving Objects, Differentiates Pedestrians from Other Moving Objects in Video Surveillance Systems 3Dinosaur breathing study shows that noses enhanced smelling and cooled brain 2Dinosaur breathing study shows that noses enhanced smelling and cooled brain 3Stem cell discovery challenges dogma on how fetus develops; holds insights for liver cancer and reg 2Stem cell discovery challenges dogma on how fetus develops; holds insights for liver cancer and reg 3
Other Contents